PV 3 Flashcards

1
Q

What is the primary focus of pharmacogenetics?

A

The genetic basis of adverse drug reactions (ADRs) and variability in drug response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What factors contribute to inter-individual variability in medication response?

A
  • Pathogenesis and severity of the disease
  • Concomitant medications and drug interactions
  • Patient’s factors (age, renal and liver function, concomitant illnesses, nutrition, lifestyle)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What role do genetic factors play in drug response?

A

They can significantly affect the kinetics and dynamics of drugs, influencing non-response or toxicity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is polymorphism in the context of pharmacogenetics?

A

Inter-individual differences in DNA sequences at a specific chromosomal location existing at a frequency of more than 1% in the general population.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the three ways pharmacogenetic mechanisms can result in clinically relevant sequelae?

A
  • Altered drug metabolism and transport
  • Unexpected drug effects
  • Genetic variation in drug targets
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the significance of the Human Genome Project for pharmacogenetics?

A

It enhances the likelihood of identifying and validating genetic markers that predict adverse events and lack of efficacy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What type of adverse drug reactions (ADRs) represent an exaggeration of the drug’s therapeutic effects?

A

Dose-related adverse drug reactions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do allergic drug reactions differ from dose-related reactions?

A

Allergic reactions require prior exposure to a drug and are not dose-related.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are idiosyncratic adverse drug reactions?

A

ADRs resulting from mechanisms that are not currently understood and are largely unpredictable.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are Type A reactions in the classification of ADRs?

A

Augmented reactions that are dose-dependent and predictable based on the pharmacology of the drug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are Type B reactions in the classification of ADRs?

A

Bizarre reactions that are idiosyncratic and not predictable based on the pharmacology.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Fill in the blank: The FDA approved the first commercially available kit to measure some _______ polymorphisms in 2004.

A

P450

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the expected impact of pharmacogenetic research on disease diagnosis?

A

Diagnosis will increasingly be based on genotype rather than phenotype.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

List the types of adverse drug reactions classified traditionally.

A
  • Type A: Augmented (dose-dependent)
  • Type B: Bizarre (idiosyncratic)
  • Type C: Chemical
  • Type D: Delayed
  • Type E: Exit/End of treatment
  • Type F: Familial
  • Type G: Genotoxicity
  • Type H: Hypersensitivity
  • Type U: Unclassified
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are common examples of idiosyncratic adverse drug reactions?

A
  • Rashes
  • Jaundice
  • Anemia
  • Decrease in white blood cell count
  • Kidney damage
  • Nerve injury
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

True or False: Dose-related adverse drug reactions are usually unpredictable.

17
Q

How can genetic differences affect adverse drug reactions?

A

They may influence how an individual metabolizes or responds to drugs.

18
Q

What is the role of advanced analytical methods in pharmacogenetics?

A

They allow measurement of the influence of genes on drug kinetics or dynamics.